Does a Nitrofurazone Coated Bladder Catheter Reduce the Number of Urinary Tract Infections in Trauma
This trial is active, not recruiting.
|Conditions||trauma, urinary tract infections|
|Treatment||nitrofuranzone coated bladder catheter|
|Start date||May 2003|
|End date||September 2006|
|Trial size||216 participants|
|Trial identifier||NCT00192985, KF 01-160/02 Catheter|
Urinary tract infections occurs in trauma. We investigate whether a nitrofurazone coated can reduce the number of urinary tract infections.
|Endpoint classification||safety/efficacy study|
|Intervention model||single group assignment|
urinary tract infections
length of stay
Male or female participants at least 18 years old.
Inclusion Criteria: - Clinical suspicion of multiple trauma - Age >/= 18 years - Direct referral from scene of accident - Indication for urinary bladder catherization Exclusion Criteria: - Major burn injury - HIV positiv - Pregnancy
|Description||Urinary tract infection occurs in one in five patients as a complication following severe trauma. A new and approved urinary bladder catheter (Releen NF) has been introduced by the Danish company Coloplast A/S. Releen NF is expected to reduce the number of urinary tract infections, but this effect has not been investigated in trauma patients.|
Call for more information